DYAI
Price
$1.05
Change
-$0.02 (-1.87%)
Updated
Jul 31 closing price
Capitalization
38.26M
9 days until earnings call
Intraday BUY SELL Signals
VRAX
Price
$2.62
Change
-$0.18 (-6.43%)
Updated
Jul 31 closing price
Capitalization
2.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

DYAI vs VRAX

DYAI vs VRAX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DYAI vs. VRAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYAI is a Buy and VRAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (DYAI: $1.05 vs. VRAX: $2.62)
Brand notoriety: DYAI and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYAI: 24% vs. VRAX: 6%
Market capitalization -- DYAI: $38.26M vs. VRAX: $2.09M
DYAI [@Biotechnology] is valued at $38.26M. VRAX’s [@Biotechnology] market capitalization is $2.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYAI’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • DYAI’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, both DYAI and VRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYAI’s TA Score shows that 6 TA indicator(s) are bullish while VRAX’s TA Score has 1 bullish TA indicator(s).

  • DYAI’s TA Score: 6 bullish, 5 bearish.
  • VRAX’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, DYAI is a better buy in the short-term than VRAX.

Price Growth

DYAI (@Biotechnology) experienced а -11.76% price change this week, while VRAX (@Biotechnology) price change was -17.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

DYAI is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYAI($38.3M) has a higher market cap than VRAX($2.09M). DYAI YTD gains are higher at: 11.702 vs. VRAX (-69.693). VRAX has higher annual earnings (EBITDA): -5.46M vs. DYAI (-6.84M). DYAI has more cash in the bank: 5.61M vs. VRAX (3.35M). VRAX has less debt than DYAI: VRAX (538K) vs DYAI (5.05M). DYAI has higher revenues than VRAX: DYAI (1.67M) vs VRAX (2.99K).
DYAIVRAXDYAI / VRAX
Capitalization38.3M2.09M1,834%
EBITDA-6.84M-5.46M125%
Gain YTD11.702-69.693-17%
P/E RatioN/AN/A-
Revenue1.67M2.99K56,028%
Total Cash5.61M3.35M168%
Total Debt5.05M538K939%
FUNDAMENTALS RATINGS
DYAI: Fundamental Ratings
DYAI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYAIVRAX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 26 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DYAI
Daily Signal:
Gain/Loss:
VRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRAB3.500.10
+2.94%
Grab Holdings Limited
OBT38.250.48
+1.27%
Orange County Bancorp Inc
NMRK14.99-0.08
-0.56%
Newmark Group
SDA0.76-0.03
-3.98%
SunCar Technology Group
NEXR3.53-43.18
-92.44%
Nexera Technologies Ltd